Loading clinical trials...
Loading clinical trials...
Active Surveillance With or Without a 6 Months Apalutamide Treatment in Low Risk Prostate Cancer: A Phase II Randomized Multicenter Trial
Conditions
Interventions
Apalutamide
Locations
13
France
Institut Paoli Calmettes
Marseille, Bouches du Rhône, France
Hôpital de Cannes
Cannes, France
CHRU Hopital Edouard Herriot
Lyon, France
Clinique Beau Soleil
Montpellier, France
Chu Hotel Dieu
Nantes, France
Chu de Nice
Nice, France
Start Date
April 28, 2017
Primary Completion Date
October 8, 2024
Completion Date
October 8, 2024
Last Updated
March 20, 2026
NCT06117059
NCT07168616
NCT01877070
Lead Sponsor
Institut Paoli-Calmettes
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions